2001 – 2009 – USADA Funded Research
During the period from 2001-2009, USADA budgeted $2 million per year to support research related to the deterrence of the use of performance-enhancing drugs in sport. USADA supported research in a variety of areas, including anabolic steroids, growth hormone, oxygen transport-enhancing substances, genetic doping, Isotope Ratio Mass Spectrometry, and ethics, among other topics. View past USADA funded research projects.
2009 – Present: The Partnership for Clean Competition
Since 2009, the broad range of anti-doping research activities previously undertaken by USADA has been assumed by the Partnership for Clean Competition.
The Partnership for Clean Competition (PCC) was founded in 2008 by the U.S. Olympic & Paralympic Committee, the National Football League, Major League Baseball, and the U.S. Anti-Doping Agency as a non-profit corporation. In addition to the founding partners, the National Basketball Association, the National Hockey League, the PGA Tour, and the National Collegiate Athletic Association are contributors.
By combining the resources and expertise of America’s leading sports entities, the PCC supports non-partisan and independent scientific research through targeted grants to various universities and other world-class research institutions. The PCC encourages independent research focusing on the development of more effective tests for performance-enhancing substances, the societal causes of doping, and non-test based methods to decrease doping and performance-enhancing drug use across all levels of athletic participation and competition, from the casual youth sports participant to the elite amateur and professional athlete.
Learn more about the Partnership for Clean Competition.
Ongoing Directed Research
USADA will still consider funding research projects that have been presented to the PCC (or World Anti-Doping Agency) first based on the guidelines from the USADA Research Priorities Policy. Learn more.